Shares of Proteome Sciences plc (LON:PRM – Get Free Report) traded up 9% on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares traded hands during trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Performance
The stock has a market cap of £9.89 million, a P/E ratio of -335.00 and a beta of 0.07. The company has a 50-day simple moving average of GBX 2.72 and a 200-day simple moving average of GBX 3.15.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- What is Insider Trading? What You Can Learn from Insider Trading
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Investing In Preferred Stock vs. Common Stock
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Using the MarketBeat Dividend Tax Calculator
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
